Navigation Links
Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
Date:12/13/2007

hem expand their offering of the most advanced treatments and technologies, build integrated community-based cancer care centers, improve their therapeutic drug management programs, and participate in many of the new cancer-related clinical research studies. US Oncology also provides a broad range of services to pharmaceutical manufacturers, including product distribution and informational services such as data reporting and analysis.

According to the company's last quarterly earnings report, US Oncology is affiliated with 1,164 physicians operating in 443 locations, including 91 radiation oncology facilities in 39 states.

About US Oncology Research Network

The US Oncology Research Network is an established community-based research operation specializing in all phases of cancer clinical trials. The research network currently has 500 physicians actively enrolling patients, 77 research sites, and is currently involved in more than 60 open research trials. The network has contributed to the development of 24 of 30 of the latest cancer-fighting drugs approved by the Food and Drug Administration for use. Since 1993, more than 32,000 patients have participated in clinical trials managed by US Oncology network practices. For more information, visit the "Research" section under "Our Services" on the company's Web site, http://www.usoncology.com.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Contact: Noelle Boyd

sanofi-aventis


'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
2. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
3. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
4. Brostallicin Trial Data Demonstrates Encouraging Anti-tumor Activity in Patients With Chemotherapy-Resistant Cancers
5. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
6. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
7. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
8. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
9. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
10. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
11. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... “Rapid technological advances will spread ... increasing unemployment, depressing American consumer spending and further ... Catch 22—we need automated manufacturing if we are ... says economist and corporate relocation expert Dr. Ron ... Pro-Business States for 2014, co-published with the American ...
(Date:7/31/2014)... Fla. (PRWEB) July 31, 2014 The Kidney ... distribution of its monthly news magazine, Kidney Cancer News. ... a presence on a website maintained by an international news ... an immediate increase in viewers.” , This month’s program highlights ... kidney tumors analyzed in a recent study. Kidney Cancer ...
(Date:7/30/2014)... 30, 2014 Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... highlights for the quarter ended June 30, 2014 on ... close. Regulus will host a conference ... 5:00 pm Eastern Daylight Time to discuss its second ...
(Date:7/30/2014)...  Decision Resources Group finds that the majority ... the United States believe that ... be the level of savings achievable by their ... cost to patients. Payers plan to leverage preferential ... expectations in order to encourage physician prescribing of ...
Breaking Biology Technology:ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3
... N.C., May 11, 2011 Micell Technologies, Inc. ... presented at the EuroPCR conference in Paris, France ... "MiStent DES: A Novel Third Generation DES with ... The MiStent Drug-Eluting Coronary Stent System ("MiStent DES") ...
... 2011 Reportlinker.com announces that a new market ... Healthcare Information Technology ... REPORT HIGHLIGHTS * BCC estimates ... technologies covered in this report at more than ...
... Research being presented at Digestive Disease Week ... benefits for qualifying patients undergoing bariatric surgery, the ... considered when determining whether the surgery is appropriate ... of physicians and researchers in the field of ...
Cached Biology Technology:Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR 2Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR 3Reportlinker Adds Healthcare Information Technology 2Reportlinker Adds Healthcare Information Technology 3Reportlinker Adds Healthcare Information Technology 4Reportlinker Adds Healthcare Information Technology 5Reportlinker Adds Healthcare Information Technology 6Reportlinker Adds Healthcare Information Technology 7Reportlinker Adds Healthcare Information Technology 8Reportlinker Adds Healthcare Information Technology 9Reportlinker Adds Healthcare Information Technology 10Reportlinker Adds Healthcare Information Technology 11New approaches, technological advances offer promise for obesity treatment 2
(Date:7/31/2014)... is available in German . ... up gases similar to a sponge that soaks up ... storing hydrogen or greenhouse gases. However, loading of many ... of Technology (KIT) now report in Nature Communications ... the MOF surface. This can be prevented by water-free ...
(Date:7/31/2014)... July 31, 2014 -- Do people make a rational ... raise them that way? Is it a matter of ... and a colleague from Rice University say that neither ... people lean left while others lean right. , A ... deep-seated psychology are at the core of political differences, ...
(Date:7/31/2014)... first discovered the photovoltaic effect in 1839, humankind has ... sunlight for its own purposes. In a new research ... FASEB Journal , scientists may have ... sunlight by focusing on a naturally occurring combination of ... conservationor persistence over time and across speciessuggests that this ...
Breaking Biology News(10 mins):Free pores for molecule transport 2Scientists find growing consensus: Political attitudes derive from body and mind 2Scientists shine bright new light on how living things capture energy from the sun 2
... the American Association of University Women (AAUW), will be ... Meeting of the Entomological Society of America (ESA). Her ... on Sunday, November 13, 2011. An important subtheme ... area where ESA President Delfosse feels there is an ...
... Researchers at Hewlett Packard and the University of ... physical and chemical properties of an electronic device that ... Memristors, short for memory resistors, are a newly ... have inspired experts to seek ways of mimicking the ...
... Gene expression is the process of converting the ... product such as a protein or any of several ... gene programs regulated by different physiological processes throughout the ... specialized cell. But a new study by researchers from ...
Cached Biology News:Christianne Corbett to speak at Entomology 2011 2'Computer synapse' analyzed at the nanoscale 2Plasticity of hormonal response permits rapid gene expression reprogramming 2
... industry's first siRNA sequence design software in ... these tools consistent with new experimental strategies ... of RNAi. With the introduction of ... tools, OligoEngine is pleased to offer the ...
... perform many sophisticated DNA analysis and protein analysis ... just another sequence analysis product. Imagine having the ... to be performed each time you have a ... which specify exactly how your output will look ...
... Western Blot Signal Enhancer does for enzyme-/substrate-based blotting ... it increases the signal up to 10-fold (or ... ,The Western Blot Signal Enhancer membrane treatment ... added to your current Western blotting protocol. ...
These stopping screens are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 screens....
Biology Products: